c**i
发帖数: 265 | 1 有些药厂的scientist位置要求postdoc经验。这个一般是强制要求么？没有postdoc经
验完全不考虑么？谢谢大家。具体公司是regeneron和pfizer。 |
|
|
|
g****3
发帖数: 2 | 4 谢谢！他们大概对我的地道江苏英语不太自信。希望听听我的报告。一小时啊！ |
|
|
|
|
|
|
B***n
发帖数: 55 | 10 好像确实，不过limo和taxi价钱上差别不大
这年月在小公司比大公司好混多了
尤其regeneron，光股票就赚翻了 |
|
|
I******e
发帖数: 36 | 12 兴冲冲期盼着来看前辈们的指点，有些失望呀。
我过去几周和1-4都接触了下，感觉这几个还是有些差别的。
Biogen Scientist I基本就像学术圈的postdoc那样干活，自主性不高，有点像没有发
表论文压力的博士后；Serono像是做产品的，不大care研究，上司manager有很多药厂
经验，但是不是PhD水平的研究工作者，更像是business manager。理解可能有误，纯
评价他们看中我简历要我面试的岗位情况。可能我较弱，只有这种档次的会相中我。
Celgene Scientist II一般要3-5年博后经验，但是好像也愿意考虑背景高度match刚毕
业的候选人。Scientist II没有自己的助手，但是可以找团队里principal scientist
的associate scientist帮忙。
Amgen的Scientist都有自己的1-2个助手，在开始的时候上司会有固定项目布置，自己
也可以propose。Amgen South San Francisco 现在非常注重research，也开始鼓励发
表学术论文，有点像Genentech那样，走起了hard... 阅读全帖 |
|
t**n
发帖数: 4365 | 13 regeneron is another example |
|
t**n
发帖数: 4365 | 14 regeneron is another example |
|
w***z
发帖数: 31 | 15 I would like to inform an incoming career symposium that should be of great
interest and benefits to many people in this board (I am also wondering
whether Banzhu could put this post atop for some time so that more people
see it?)
The career symposium:
Chinese Life Science Professionals Association (CLSPA) is hosting the CLSPA
Career Symposium 2010 on October 30th at the Hammer Building, Columbia
University Medical Center.*The symposium will introduce broad career options
, offer insider's caree... 阅读全帖 |
|
p*********r
发帖数: 14 | 16 大家好，这个工作机会我可以推荐。 请发简历至 p**************[email protected] 请
title 上注明 身份： 例如 绿卡，公民，OPT， H1 transfer 请抓紧时间。谢谢
Job Title:SAS Programmer
Location:Atlanta, GA
Type: Full time
PROJECT DESCRIPTION:
A statistical programmer provides timely support to the study team on all
programming matters according to the project strategies. Requirements will
be identified according to a Statistical Analysis Plan and programming
specifications using internal standards and guidelines. Should have the
ability to generate all ... 阅读全帖 |
|
s****1
发帖数: 8 | 17 药厂统计的话，到底是新泽西还是波士顿几乎多啊？
听说波士顿主要是小公司，或大公司的某个部门，如novartis early development。新
泽西好像大药厂多一点，小药厂也不少，如最近比较红火的celgene regeneron。如果
这样的话，还是NJ好一点？ |
|
d***e
发帖数: 193 | 18 NYC和NJ很多这样的机会，比如Memorial Sloan Kettering Cancer Center，经常招人
，还有BMS，Novartis，Merck，Celgene和Regeneron这样的药厂，还有Health First这
类的healthcare公司，另外还有一些CRO类的公司，和做clinical data analysis的
consulting类的公司，比如medidata，medivo都是中小型公司了。
你多到他们网站上去看看，这些公司对SAS要求比较高，如果有证书被看中的几率会大
些。 |
|
d***e
发帖数: 193 | 19 NYC和NJ很多这样的机会，比如Memorial Sloan Kettering Cancer Center，经常招人
，还有BMS，Novartis，Merck，Celgene和Regeneron这样的药厂，还有Health First这
类的healthcare公司，另外还有一些CRO类的公司，和做clinical data analysis的
consulting类的公司，比如medidata，medivo都是中小型公司了。
你多到他们网站上去看看，这些公司对SAS要求比较高，如果有证书被看中的几率会大
些。 |
|
i***m
发帖数: 148 | 20 感觉你这个说的就片面了吧。
波士顿就被无视了？biotech最火的地方就是波士顿了吧。
而且你说的biomarin，gilead最近股票都很一般啊，别说几倍的涨了，gilead都跌了不
少。
去了几个月就被收购的，拿到手的股票也没多少吧？
大公司怎么就只卖现成的药了呢？这不是把几大巨头都给无视了吗？Pfizer，Merck，
Novartis，Lilly，BMS，Regeneron，Roche这些大公司每年都有新药出来啊，怎么就不
需要biostatistician了呢？
当然我同意你说的，富贵险中求，攒点经验还是去小公司更有得赚
了。 |
|
i***m
发帖数: 148 | 21 感觉你这个说的就片面了吧。
波士顿就被无视了？biotech最火的地方就是波士顿了吧。
而且你说的biomarin，gilead最近股票都很一般啊，别说几倍的涨了，gilead都跌了不
少。
去了几个月就被收购的，拿到手的股票也没多少吧？
大公司怎么就只卖现成的药了呢？这不是把几大巨头都给无视了吗？Pfizer，Merck，
Novartis，Lilly，BMS，Regeneron，Roche这些大公司每年都有新药出来啊，怎么就不
需要biostatistician了呢？
当然我同意你说的，富贵险中求，攒点经验还是去小公司更有得赚
了。 |
|
v**********m
发帖数: 5516 | 22 You guys now are able to listen to these web-castings now. Enjoy it!
http://jpmorgan.metameetings.com/webcasts/healthcare11/ondemand
individual Company Presentations
A
Abbott
Abiomed Inc. (available to Feb. 5)
Ablynx N.V.
Accretive Health Inc.
Accuray Inc.
Acorda Therapeutics, Inc. (available to Feb. 11)
Actelion Ltd
Aetna Inc. (available to Feb. 8)
Affymetrix Inc.
Agilent Technologies Inc.
Albany Molecular Research Inc.
Alere Inc (available to Feb. 11)
Alexion Pharmaceuticals, Inc. (not availab... 阅读全帖 |
|
v**********m
发帖数: 5516 | 23 You guys now are able to listen to these web-castings now. Enjoy it!
http://jpmorgan.metameetings.com/webcasts/healthcare11/ondemand
individual Company Presentations
A
Abbott
Abiomed Inc. (available to Feb. 5)
Ablynx N.V.
Accretive Health Inc.
Accuray Inc.
Acorda Therapeutics, Inc. (available to Feb. 11)
Actelion Ltd
Aetna Inc. (available to Feb. 8)
Affymetrix Inc.
Agilent Technologies Inc.
Albany Molecular Research Inc.
Alere Inc (available to Feb. 11)
Alexion Pharmaceuticals, Inc. (not availab... 阅读全帖 |
|
y*****l
发帖数: 5997 | 24 http://www.thestreet.com/story/11131722/1/biotech-calendar-2011
Biotech Calendar: 2011 FDA Drug Approvals
By Adam Feuerstein 05/25/11
BOSTON (TheStreet) -- The 2011 FDA drug approval calendar has been updated.
For easier reference, this regulatory calendar is organized in chronological order based on the drug approval decision date. Information on pending FDA advisory panels is also included.
Optimer Pharmaceuticals(OPTR_)
Drug/indication: Dificid for Clostridium difficile infection
FDA approval... 阅读全帖 |
|
y*****l
发帖数: 5997 | 25 http://www.thestreet.com/story/11131722/1/biotech-calendar-2011
Stock quotes in this article:SPPI, CTIC, TSPT, SGEN, ANX, PATH, OPTR
http://finviz.com/screener.ashx?v=341&t=SPPI,CTICD,TSPT,SGEN,AN
Biotech Calendar: 2011 FDA Drug Approvals
By Adam Feuerstein 05/25/11
BOSTON (TheStreet) -- The 2011 FDA drug approval calendar has been updated.
For easier reference, this regulatory calendar is organized in chronological
order based on the drug approval decision date. Information on pending FDA
advis... 阅读全帖 |
|
y*****l
发帖数: 5997 | 26 http://www.thestreet.com/_yahoo/story/11215926/1/biotech-calend
Updated with corrected FDA approval decision date for Roche's melanoma drug
Zelboraf. It's Oct. 28, 2011, not Nov. 11, 2011, as previously reported.
BOSTON (TheStreet) -- The 2011 FDA drug approval calendar has been updated
and extended through the first quarter of 2012.
For easier reference, this regulatory calendar is organized in chronological
order based on the drug approval decision date. Information on pending FDA
advisory pan... 阅读全帖 |
|
K********g
发帖数: 9389 | 27 【 以下文字转载自 Stock 讨论区 】
发信人: KeepBuying (雁过留声), 信区: Stock
标 题: 2011年11月-2012年1月的FDA的NDA医药股
发信站: BBS 未名空间站 (Wed Nov 2 00:25:56 2011, 美东)
既然成为板斧了，那就为股版添点东西。
下面的医药股是2011年11-2012年1月的FDA的NDA待审批的。大家记住，任何药股的NDA
风险都比较大，要学会炒药股，切忌去赌药股的NDA.下面带星号的我觉得还可以值得研
究。
12/8/2011 Antares Pharma Inc. AIS Anturol Gel (NDA) FDA decision
on Anturol Gel for overactive bladder
12/7/2011 AFFYMAX INC AFFY Peginesatide (NDA) FDA panel to
review Peginesatide for anemia associated with chronic... 阅读全帖 |
|
|
W********g
发帖数: 610 | 29 06/29/2012 Astellas Pharma Inc. ALPMY.PK, ALPMF.PK Mirabegron (NDA) FDA
decision on Mirabegron for proposed treatment of overactive bladder
-News
06/28/2012 Bristol-Myers Squibb Co. BMY ELIQUIS (NDA) FDA decision on
ELIQUIS for prevention of stroke and systemic embolism in patients with
atrial fibrillation
06/27/2012 Arena Pharmaceutical Inc. ARNA Lorcaserin (NDA) FDA decision on
Lorcaserin for proposed treatment of obesity
06/21/2012 Repligen Corp RGEN SecreFlo... 阅读全帖 |
|
